Cipla wins portion of state ARV tender
DATE: 4 March 2019
AUTHOR: Medical Academic
Cipla, South Africa’s third largest pharmaceutical manufacturer, announced that it has been awarded a contractual share of the National ARV Tender for TEE and TLD, effective from 1 July 2019 and valid for three years.
To read the full article online click here.